Pharma Company Selects OmniComm Platform

Article

OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BA clinic.

OmniComm Systems announces the selection of its Trial One platform by a pharmaceutical company to automate its Phase I and BA/BE clinic. The company aims to standardize its processes, improve business intelligence, ensure compliance, and transform its overall business within its early phase research.

Read the full release here

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.